Abstract
No single theory of pathogenesis can properly account for human kidney stones, they are too various and their formation is too complex for simple understanding. Using human tissue biopsies, intraoperative imaging and such physiology data from ten different stone forming groups, we have identified at least three pathways that lead to stones. The first pathway is overgrowth on interstitial apatite plaque as seen in idiopathic calcium oxalate stone formers, as well as stone formers with primary hyperparathyroidism, ileostomy, and small bowel resection, and in brushite stone formers. In the second pathway, there are crystal deposits in renal tubules that were seen in all stone forming groups except the idiopathic calcium oxalate stone formers. The third pathway is free solution crystallization. Clear examples of this pathway are those patient groups with cystinuria or hyperoxaluria associated with bypass surgery for obesity. Although the final products may be very similar, the ways of creation are so different that in attempting to create animal and cell models of the processes one needs to be careful that the details of the human condition are included.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
No single theory of pathogenesis can properly account for human kidney stones, they are too various and their formation is too complex for simple understanding. Using human tissue biopsies, intra-operative imaging and such physiology as can be accomplished in humans, we have identified at least three pathways that lead to stones. Although the final product may be very similar, the way to achieve it is so different that in attempting to create animal and cell models of the process one needs to be careful that the details of the human condition are included.
The first pathway: overgrowth on interstitial apatite plaque
Plaque has been noticed for seven decades at least. Using modern digital imaging endoscopes one readily finds stones growing on plaque [1, 2] (Fig. 1a) as Randall did long ago at post-mortem [3]. On biopsy, plaque forms in the basement membranes of thin limbs of Henle’s loop [4] (Fig. 1b) as fine particles stained black here (arrows). No tissue reaction or cell injury occurs. On transmission electron microscopy (Fig. 1c), particles are laminated microspherules of alternating white apatite crystals and black appearing organic matrix that coalesce in the interstitium to form a syncytium in which islands of crystal float in an organic sea (Fig. 1d); the material readily migrates without crossing any anatomical barriers from its site of formation to the sub-urothelial space in which it can be seen from outside as the white plaque. Within plaque micro-spherules, osteopontin locates itself along the crystal–matrix boundary (Fig. 1e, black dots) [5], whereas the third heavy chain of the inter-alpha trypsin inhibitor lies in the matrix [6] (Fig. 1f, dots at arrow).
All this is common in idiopathic calcium oxalate (CaOx) stone formers (ICSF), by which we mean CaOx stone formers with no known systemic disease apart from familial (idiopathic) hypercalciuria (IH). Plaque is also found in stone formers with primary hyperparathyroidism, ileostomy, and small bowel resection, and in brushite stone formers. However, the details for stone formation on plaque have been elucidated only in ICSF thus far.
In an ICSF, a small (1 mm) stone is growing over plaque (Fig. 2a, arrow) on a papillum; it was detached with its tissue underpinnings in which the plaque base is easily seen (Fig. 2b, arrow) [7]. After mineral has been removed, the slightly flattened stone is oriented floating above its old attachment site (Fig. 2c) where a large base of plaque, stained black lies just below a small black plaque remnant on the stone (*). Remnants of urothelial cells lie on the stone (arrowheads) and at the margins of the denuded attachment site (arrows).
Below Fig. 2c, using TEM, plaque within the original tissue base of the stone lies under a folded multi-layered ribbon that forms an outer boundary between denuded plaque and what was the urinary space (Fig. 2d; plaque at lower right, ribbon at ‘A’). The ribbon is layered apatite crystals, white, alternating with black appearing organic matrix, and over it crystals have formed in rafts and layers (*, and double arrows). An enlarged view (inset) shows the ribbon crystals aligned perpendicular to the long axis of the ribbon at small arrows. In other words, the exposed plaque was covered over by matrix (the layer immediately adjacent to the plaque) which then was covered by successive layers of crystal nuclei and more matrix; nucleation created about seven layers, until the crystallization escaped from matrix and proceeded to form a stone proper.
The crystal deposits under the ribbon (Fig. 3a, double dotted line), which belong to plaque itself (black arrows), are apatite (Fig. 3b, colored lowest arrow points from FTIR spectrum to crystal region); the vertical lines on the spectrum graph highlight the apatite signature peak (Fig. 3b). Within the ribbon, the interface of plaque and new stone, apatite also predominates, but in an amorphous state giving a broadened band. Above that, at region 1 (Fig. 3a), one finds apatite again, like that in plaque; this is already within the stone itself. By region 2 (Fig. 3a), well within the stone body, CaOx (at arrowhead) admixes with apatite and by the outermost region, region 3 (Fig. 3a), CaOx is alone.
The matrix at the interface contains osteopontin (Fig. 3c) which is in urine and plaque alike and so crosses the interface without discontinuity. Tamm Horsfall protein (THP) present in urine but not renal papillum is in the matrix outside the interface, but not within (Fig. 3d). From this, we infer that the original plaque exposed to urine was covered over with molecules of urine origin, including THP and osteopontin, crystals formed in it driven by urine supersaturations (SS), among which those for calcium phosphate were paramount, and a ribbon of alternating matrix and crystal resulted. Eventually, urine SS drove enough crystallization to escape from matrix modulation, more apatite formed and CaOx came to predominate. How and why that crystal transition occurs is not known. One possibility is that the original matrix covering is conditioned by the plaque affinities for urine molecules and later matrix is simply what layers of amorphous apatite attract. Possibly, formation of apatite lowers local pH essentially self-extinguishing apatite development so CaOx begins to predominate. This is a crucial area for new research.
The driving forces must include supersaturation for calcium phosphate as well as CaOx if we are to have the ribbon and the initial phases of a CaOx stone attachment and in fact, ICSF have both (Fig. 4 ) [8]. Because they are generally hypercalciuric from IH, ICSF have much higher urine calcium molarities than normals (solid and crosshatch bars, upper left panel), and the difference becomes more marked as day wanes into night. Oxalate molarities, pH, and volume are not different in this diet controlled GCRC daylong study. SS CaOx is higher in ICSF than normals, but present in both. SS CaP is not present in N, but is marked in ICSF, especially overnight. Therefore, the crystal patterns we observe, apatite initiation followed by CaOx overgrowth could be driven in SF but not well in normals. IH is clearly of paramount importance for apatite, but high urine oxalate could do as well as high calcium for the CaOx component.
This is all about ICSF; for the other conditions in which CaOx stones grow over plaque, we do not have this kind of refined mechanistic analysis. Brushite and hyperparathyroid SF have hypercalciuria and high CaP SS, so the system of overgrowth could proceed. But ileostomy and small bowel resection are acid urine states, so the initial crystal phases may not be apatite; this is a crucial open research question.
Plaque itself cannot, of course, be driven from urine SS as it forms within the papillum, and in fact within a basement membrane, so we have to look elsewhere for mechanisms. Our beginning was simply physiology correlations: with what urine measurements, if any, did plaque abundance correlate? For ICSF, normals and obesity bypass SF, plaque abundance, measured as fraction of papillae covered, varies directly with urine calcium excretion (Fig. 5, upper left panel) and inversely with urine volume and pH (upper middle and right panels) [9]. Combined multivariate scores which include urine volume, pH, and calcium (bottom panels) correlate very well with plaque. From this we deduce that IH, urine acidification and water conservation all play a role, which is not a surprise given the origin of plaque in the thin loops of Henle. Water conservation would naturally raise concentrations of calcium salts along the loop, and acidification of tubule fluid in collecting ducts must raise the pH of the interstitium, so as a first approximation the effects of volume and pH seem accessible to experiment.
The effects of calcium excretion, which arises from IH in ICSF, are not immediately obvious because the physiology of IH is itself complex and not fully understood. Recent work by our group has shown that the high urine calcium excretion of IH is a mealtime phenomenon: with each meal, fractional renal tubule calcium reabsorption falls (Fig. 6 lower right panel) at fixed levels of filtered load and with no difference of ultra-filtrate or serum calcium concentration between IH and normals (Fig. 6, remaining panels) [10]. Therefore, if IH contributes to plaque, it must do so in part because of the altered tubule function from which it arises.
At least the proximal tubule is abnormal in IH (Fig. 7). Using endogenous lithium clearance measurements, we found that with meals proximal tubule reabsorption of IH falls far more than in normals so that distal nephron calcium delivery is increased [11]. Urine calcium excretion is in fact roughly proportional to distal delivery as in the figure. Delivery of abnormally large amounts of calcium down the thin limbs and to the thick ascending limb offer possible mechanisms for plaque, which are being explored in new research. Links to plaque in the other conditions are not as well established and therefore we do not discuss them here, in this review, at this time.
One might rightly ask for a trial to prove that howsoever attractive our pictures of stone overgrowth, this is indeed the main, or even exclusive mode for stone formation in ICSF. To test this we used a kind of gambler’s experiment: for a series of stones in successive ICSF patients, with no stones excluded from the count, what fraction of stones were found attached, and of those attached, what fraction were attached to plaque [12]? Among 9 patients, 12 kidneys, 115 stones, 90 were found attached; the 25 unattached, incidentally all had residual apatite cores that could have served as attachment sites. Of the 90, 81 were on plaque as determined at operation and on reviewing intra-operative movies later on. The other nine were on plaque at surgery but the movies were not clear enough to be sure. From these numbers, using proper mathematics, and allowing for within patient correlation we determined that the true attachment rate had to be at least 75% (95% CI for estimate was 58–93%) and the trial was stopped. Of note, as seen on our figures, plaque occupies no more than 5% of papillary area. Our hypothesis was that growth on or off plaque was equally probable. It was rejected at p < 0.05. Had we used the proper figure, that by chance 5% of stones would be on plaque, the trial could have been far smaller. Plaque is clearly a powerful accumulator of stones in that the small fraction of papillary surface covered by plaque accumulates the vast majority of stones; this means they grow there and plaque is essential to their existence.
ICSF are the most pure example of the first pathway. They form their CaOx stones by overgrowth on plaque, driven by urine SS values that are clinically accessible and modifiable. Plaque is itself a reflection of mechanisms that alter urine volume pH and calcium excretion and its formation may be subject to clinical interventions; trials are a worthwhile possibility given ways to measure plaque non-invasively. Since ICSF are very common, the first pathway is probably the main one operating in the usual patient. Of note, plaque is seemingly benign in that tissues around it do not show inflammation or fibrosis. We have made no mention of crystals within tubules because none has thus far been found in ICSF [13]. Perhaps for these reasons, renal function is well preserved in most patients apart from effects of stones, obstructions, instrumentations, and infections.
The second pathway: crystal deposits in renal tubules
By contrast, all other stone formers are prone to deposit crystals in their tubules and these deposits may be related to stone formation. Brushite stone formers [14] (Fig. 8) form apatite deposits in ducts of Bellini (BD) and inner medullary collecting ducts (IMCD) that can massively dilate the duct and even protrude from its mouth into the urinary space (Fig. 8a). On biopsy (Fig. 8b) the dilated duct has no epithelial cell lining remaining and is surrounded by interstitial fibrosis. Deposits appear as elongate yellow tinted risings beneath the urothelium (Fig. 8c, single arrows) easily distinguished from white interstitial plaque (double arrow). Biopsy through the yellow region in the middle upper panel reveals a deposit (Fig. 8d, at *) just below the urothelium (at arrow). Biopsy tissue highlights the extensive, though focal, damage one can find (Figs. 8e, f). Huge deposits replace epithelial cells and interstitial fibrosis is marked. The full pathogenesis remains a matter of research, presently; crystal mediated injury, reasons for the crystal deposits, and possible role of shock wave lithotripsy—a well established cause of focal papillary injury—all require study.
But even now, some elements are clear. Calcium phosphate crystals will form in BD and IMCD more readily as urine CaP SS rises, because tubule fluid in these segments closely tracks the composition of the final urine [15]. As average stone CaP percent rises (X axes of all 6 panels in Fig. 9), CaP SS (upper left panel) rises because of increasing urine pH (upper middle panel). Increasing hypercalciuria (upper right panel) plays a less constant role, and changes in urine volume, phosphate excretion, and citrate excretion are too variable to have been a consistent cause. Therefore, for pathogenesis of BD and IMCD CaP deposits, as for pathogenesis of CaP stones, the mechanism is high SS, itself driven by a higher average urine pH than found in ICSF and we are left with the question of how urine pH is increased.
One culprit may be SWL (Fig. 10) [15]. Looking for covariates of urine pH, we stumbled on SWL, and no amount of correcting for confounders can remove its effects. When stone CaP percent is regressed on number of extra corporeal shock wave lithotripsies (ESWL) and one allows for sex, age, years of stone disease and numbers of stones formed, the relationship is a strong one (Fig. 10). This is also true for those patients who convert from CaOx to CaP stones [16]. SWL can surely injure papillae and medulla, so perhaps this modern and valuable treatment for stones has its dark side.
The same pattern of deposits occurs in patients with primary hyperparathyroidism, but in a less pure form [17]. Like brushite SF, these patients produce BD and IMCD deposits that can protrude from the mouths of dilated BD (Fig. 11a, arrow) and appear as yellow elongate structures (double arrowheads). But they also produce considerable interstitial apatite plaque (Fig. 11a, at single arrowhead); this specific region was the attachment site of a CaOx stone that has been removed. Just above it (in inset box) a CaOx stone remains attached (detailed in blowup box). The massive extent of tubule plugging is seen in biopsy tissue (Fig. 11b, arrows). Figure 11c and d illustrates how extensive white plaque (arrowheads) can be as seen endoscopically and on biopsy. Plugging and plaque coexist in nearby regions (arrow shows plugging, arrowheads show plaque in a single biopsy section). By endoscope, a large attached CaOx stone resides on a region of white plaque (Fig. 11e, *); unoccupied white plaque is scattered about (single arrowhead) and yellow plaque, meaning BD and IMCD deposits, lies just nearby (double arrowheads). The stone (Fig. 11f) from Fig. 11e, detached, shows, on light microscopy, calcium oxalate dihydrate (COD) planar crystals (arrows) more dramatic in micro-CT analysis (Fig. 11g). In the CT image, the brighter streaks are apatite; the sided planar gray is COD. Therefore, in hyperparathyroidism, the first and second pathways coexist: CaOx stones grow over apatite interstitial plaque, while nearby, often within a single biopsy sample one finds BD and IMCD plugged with apatite crystals.
How the plugging occurs is not too mysterious given what we have already said about brushite patients. Compared to normals (Fig. 12, left hand bars of each panel), and to ICSF (middle bars of each panel) urine volume, calcium, oxalate, but especially pH is high, so that SS CaOx and CaP are higher even than in ICSF [18]. One would expect CaOx and CaP stones, and that is what one finds. In fact, in our biopsied cases, collected stones were mainly CaP, even though we clearly documented small attached CaOx stones on papillae. Even how urine calcium and volume and pH get this abnormal is not a mystery given the pathophysiology of primary hyperparathyroidism, but this review must have boundaries, and we simply, at this point, direct the reader to standard textbook sources.
Perhaps the most extreme of the high pH CaP stone forming states is renal tubular acidosis, in which urine pH cannot be lowered substantially below that of blood and CaP SS is perpetually high. All tubules are involved via either heredity or such diseases as Sjogren’s syndrome. Papillae show multiple dilated BD (Fig. 13a, b, arrows) and deposits within BD (*) [19]. Distortion, flattening and fibrosis are evident. The extent of scarring and deposit formation is evident by biopsy and micro-CT analysis (Fig. 13c, d; deposits at arrows). At higher magnification (Fig. 13e, f) the extent of fibrosis is highlighted. Atrophic remnants of nephron structures lie within fibrotic fields of interstitium. White plaque is not present above normal values, and attached CaOx stone have not been found.
At this point, an astute observer might ask exactly how CaP stones form. In brushite, hyperparathyroid and RTA SF we observe CaP stones readily, and also massive amounts of CaP deposits, but do we see the stones growing as extensions of the deposits? Randall said he did see this, and called this ‘Type 2’ deposition; but we do not see the phenomenon except rarely. What we find is CaP stones free in the renal pelvis and among the calyces. We do not know, in other words, how the stones form. Clearly, the pathways to crystallization are not those of ICSF, so we are right in naming this a second pathway, but we are, when faced with the obvious question, silent.
The third pathway: free solution crystallization
Perhaps the least controversial example must be cystinuria [20]. Huge numbers of stones, often themselves large enough to fill the renal pelvis form because cystine is poorly soluble and excreted in very excessive amounts that supersaturate the urine. One expects to find, and indeed does find that stones are free in the renal pelvis and never attached. The papillae range from normal (Fig. 14a, b) to mildly or markedly involved with BD and IMCD plugging (Fig. 14c, d). As expected, BD plugs often contain cystine (Fig. 14e, f). Unlike apatite plugs, cystine plugs could never anchor stones because they are themselves mobile and slip out easily at surgery. Sometimes they grow to very large size (Fig. 14e, f) and dilate ducts markedly, but when exposed surgically the crystals wash away. Unexpectedly, apatite deposits also form (Fig. 14c–f); usually these are in IMCD, not BD, and cystine is found in BD, not IMCD. Some apatite has also been found in thin limbs, a site not involved in the other states we have described thus far. Of note, BD dilation is quite striking, and dilated IMCD filled with cast material (Fig. 14d, *) can be found surrounded by fibrotic interstitium.
We believe, and most will agree, that cystine merely crystallizes, in urine, in BD, and causes stones and BD plugging. Physicians treat this disease with alkali loading to raise urine pH and dissolve cystine, and perhaps promote apatite deposits. Urine pH of cystinuric patients runs high even without alkali treatment [21] perhaps because of BD plugging and secondary acidification defects. But in the main this is an example of the third pathway and is important, perhaps, mostly because it illustrates that even the most simplified mechanisms for crystallization can lead to complex secondary events such as apatite deposits and considerable papillary disease.
Ileostomy and colectomy with pouch are states of persistent acid urine and stones are COM and uric acid [22]. The stones are found, for the most part, free in the urinary system, and one is led to suspect that at least the uric acid component would form much as in cystinuria: an organic poorly soluble molecule in large amounts crystallizing in free solution. But this disease has a very complex tissue reflection [23]. Although at surgery the main impression is of many free stones, one can easily find white plaque (Fig. 15a, arrow) with CaOx stones growing on it (Fig. 15e). Uric acid itself, although uric acid stones form in these patients and urine has uric acid SS, is not found in BD or IMCD; instead one finds plugs of the sodium and ammonium salts of uric acid (Fig. 15c, d), which form at higher pH levels (above 6) along with apatite (Fig. 15b, f), which forms at an even higher pH.
How do urates and apatite form in the tubules? One cannot simply say the tubule fluid differs from urine in pH without meaning that somehow tubule acidification is deranged, that in some IMCD and BD tubule fluid is not acidified properly whereas in the bulk of tubules it is—leading to the low bulk phase urine pH. Spotty ‘renal tubular acidosis’ at a tubular level is not a recognized clinical entity, but we believe it must exist in this condition.
Therefore, like cystinuria, ileostomy has elements of free solution stone formation in the uric acid component and perhaps some CaOx, but is complicated. A few, but clearly very few CaOx stones grow on white plaque—the first pathway. Tubules are plugged with crystals that are not stable at the measured pH the patients produce, so second pathway is engendered, perhaps via focal tubule acidification defects. In other words, this condition exhibits all three pathways at once—or seems to. Much research is needed here.
Patients with the now obsolete obesity bypass procedure, and those with the new bariatric surgeries form CaOx stones that are round and never attached to white plaque—free in the renal pelvis. White plaque is itself very minimal [4]. In bypass patients, scattered IMCD contain small apatite plugs, even though urine pH is low; this is presumably a minor version of what we find in ileostomy: focal nephron limited renal acidification defects. Urates are never present. Yellow plaque (Fig. 16a, arrowheads) is easily seen, surrounding a dilated BD. Biopsy (Fig. 16b) reveals plugs and dilated IMCD with cast material (Fig. 16b, arrows); a protruding plug in a BD is at *. Plugs are apatite and can dilate ducts and destroy epithelium (Fig. 16c, d). Hyaluronan expression, a marker for cell injury, is increased in bypass patients (Fig. 16e, arrows) not associated with crystals, and also where crystals are present (Fig. 16f at arrowheads) [13]. The general increase of hyaluronan is never seen in ICSF and has not been looked for in other diseases; it presumably marks an otherwise unrecognized injury that could perhaps be part of the mechanism for apatite deposits, for after all they must form because of abnormal acidification and some cause of the abnormality must be presumed.
Bypass is a hyperoxaluric state, and stones are CaOx. For this reason, we exerted ourselves scanning everywhere with oil immersion polarization light microscopy looking for birefringent crystals, and found traces of them as a kind of scrim (Fig. 17a, b) over occasional IMCD cells otherwise normal appearing, and in a part of a several deposits otherwise non-birefringent (Fig. 17c, d) [13]. We presume therefore that some CaOx crystals lodge in IMCD, perhaps mediating cell injury. This is an unexplored problem to date.
Some final words
Much of the time, in doing our investigations, we feel like a tiny band of archeologists unearthing buried and mysterious ruins filled with the damaged remnants of an unknown violence. Ultimately, we must presume everything we find begins with crystallization, and crystals, being what they are, form because of supersaturations. But we are at the very beginning of a real understanding of just what these supersaturations are in specific renal locales, and how they might be produced. Like ancient wars, they will yield up their secrets and for the moment, we must be content with what we have by way knowledge, and hope to continue studying this strange biology of crystal mediated disease.
References
Evan A, Lingeman J, Coe FL, Worcester E (2006) Randall’s plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69:1313–1318
Matlaga BR, Williams JC Jr, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE (2006) Endoscopic evidence of calculus attachment to Randall’s plaque. J Urol 175:1720–1724
Randall R (1940) Papillary pathology as precursor of primary renal calculus. J Urol 44:580–589
Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616
Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145–154
Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72:1503–1511
Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec (Hoboken) 290:1315–1323
Bergsland KJ, Coe FL, Gillen DL, Worcester EM (2009) A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 297:F1017–F1023
Kuo RL, Lingeman JE, Evan AP, Paterson RF, Parks JH, Bledsoe SB, Munch LC, Coe FL (2003) Urine calcium and volume predict coverage of renal papilla by Randall’s plaque. Kidney Int 64:2150–2154
Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL (2007) Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 292:F66–F75
Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL (2008) Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol 295:F1286–F1294
Miller NL, Gillen DL, Williams JC Jr, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE (2009) A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall’s plaque. BJU Int 103:966–971
Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325–334
Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591
Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE (2004) Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66:777–785
Parks JH, Coe FL, Evan AP, Worcester EM (2009) Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 24:130–136
Evan AE, Lingeman JE, Coe FL, Miller NL, Bledsoe SB, Sommer AJ, Williams JC, Shao Y, Worcester EM (2008) Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int 74:223–229
Parks JH, Coe FL, Evan AP, Worcester EM (2009) Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 103:670–678
Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester E (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795–801
Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227–2235
Sakhaee K, Poindexter JR, Pak CY (1989) The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. J Urol 141:819–821
Parks JH, Worcester EM, O’Connor RC, Coe FL (2003) Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 63:255–265
Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC, Jr., Krambeck AE, Worcester EM (2009) Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coe, F.L., Evan, A.P., Worcester, E.M. et al. Three pathways for human kidney stone formation. Urol Res 38, 147–160 (2010). https://doi.org/10.1007/s00240-010-0271-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-010-0271-8